ArticleDrugs & therapy perspectives : for rational drug selection and use2018

Cabozantinib as first-line treatment in advanced renal cell carcinoma: a profile of its use.

Katherine A Lyseng-WilliamsonPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.